A study to see how PET scans pick up blood supply changes to ovarian cancer treated with pazopanib and paclitaxel (PAZPET 1)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Ovarian cancer

Status:

Closed

Phase:

Phase 1

Details

This study is using PET scans to see how well the drugs pazopanib and paclitaxel stop abnormal blood vessels growing in ovarian cancer that has continued to grow despite having platinum chemotherapy.

Recruitment start: 19 June 2012

Recruitment end: 30 April 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rohini Sharma

Supported by

Experimental Cancer Medicine Centre (ECMC)

GlaxoSmithKline (GSK)

Imperial College London

Medical Research Council (MRC)

NIHR Clinical Research Network: Cancer

Last reviewed: 21 November 2016

CRUK internal database number: 8045

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.